Covaxin
BHU study on Covaxin side effects poorly designed, erroneously acknowledgesICMR: Dr Bahl
Over 30% Covaxin takers suffered from health issues after 1 year, claims BHU study
No link between Covid vaccines used in India and heart attack risk: Study
ICMR study indicates Covaxin booster dose safe, necessary for persistent immunity
Booster dose of Covishield offers best immune response: Lancet study
Covishield more efficient than Covaxin against Covid variants: Study
Bharat Biotech's intranasal COVID-19 vaccine to cost Rs 800 for private markets
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/s4qPpnJyCFcbknPylEaz.jpg)
/newsdrum-in/media/media_files/OSUy36w8RkMiY0a9CJMa.jpg)
/newsdrum-in/media/media_files/se2fjoo3BFLqTmGbr4Kp.jpg)
/newsdrum-in/media/media_files/4Iviv4ItTvFfDpP44Oiw.webp)
/newsdrum-in/media/media_files/73mwGVDmOfcRo2gUDlQF.jpg)
/newsdrum-in/media/media_files/WZyQGyO7iHAtfuYYIRGx.jpeg)
/newsdrum-in/media/media_files/KSpoyvSdMSWVZPM6nR3v.jpg)
/newsdrum-in/media/media_files/VsMgx2wRKLUwLsEsV0bt.jpg)
/newsdrum-in/media/media_files/PUiDkVp7d4CMYS8Xr7UU.webp)
